Elevated lipoprotein(a) levels linked to new-onset atrial fibrillation: insights from a retrospective cohort study
Our study suggests that elevated Lp(a) (≥50 mg/dL) is an independent risk factor for incident AF. Future prospective studies are warranted to validate our results and to test if reducing Lp(a) could mitigate the burden of AF.
Authors
- Arturo M. Valverde (ORCID: https://orcid.org/0000-0003-2780-6744)
- Milagros Pereyra (ORCID: https://orcid.org/0000-0003-4695-8436)
- Hicham El Masry (ORCID: https://orcid.org/0000-0002-2470-2862)
- Komandoor S. Srivathsan (ORCID: https://orcid.org/0000-0001-9732-0243)
- Reza Arsanjani (ORCID: https://orcid.org/0000-0001-7081-4286)
- Isabel G. Scalia (ORCID: https://orcid.org/0000-0002-6459-9767)
- Said Alsidawi (ORCID: https://orcid.org/0000-0001-8750-7880)
- Ahmed Mahmoud (ORCID: https://orcid.org/0009-0009-9729-9961)
- Dan Sorajja (ORCID: https://orcid.org/0000-0003-1976-6420)
- Luis R. Scott (ORCID: https://orcid.org/0000-0002-1010-1062)
- Mayank Sardana (ORCID: https://orcid.org/0000-0001-9465-1047)
- Kamal Awad (ORCID: https://orcid.org/0000-0001-6707-1629)
- Juan Farina (ORCID: https://orcid.org/0000-0002-5824-8485)
- Nima Baba Ali
- Amro Badr (ORCID: https://orcid.org/0000-0003-0107-1436)
- Chadi Ayoub (ORCID: https://orcid.org/0000-0001-5877-7478)
- Mohammed Tiseer Abbas
- Steven J. Lester
- Anan Abu Rmilah
- Win K. Shen
- Moaz Kamel
- Timothy Barry
Institutions
- Mayo Clinic (US)
- WinnMed (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- European Journal of Preventive Cardiology
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1093/eurjpc/zwaf063
- Citations
- 6
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 12.04